Delhi govt reserves 70% vaccine slots for first dose recipients

the Delhi government on Sunday issued an order to reserve 70 per cent of vaccination slots of Covishield and Covaxin at state-run facilities

vaccination
Press Trust of India New Delhi
2 min read Last Updated : Aug 15 2021 | 7:10 PM IST

To cover more people in the COVID-19 vaccination drive, the Delhi government on Sunday issued an order to reserve 70 per cent of vaccination slots of Covishield and Covaxin at state-run facilities for those receiving the first dose.

More than 1.15 crore vaccine doses have been administered in the national capital till Sunday, of which 32,66,927 are second doses.

"First dose proportion of Covishield may be increased from 40 per cent to 70 per cent of the total slots being created and first dose proportion of Covaxin may be increased from 50 per cent to 70 per cent...," the order said.

The Delhi government had on July 22 ordered that only the second dose of Covishield vaccine will be administered at government inoculation centres till July 31 due to limited supply.

Also, only 20 per cent of the Covaxin stock was being used for the first dose due to its "irregular delivery cycles".

Earlier this month, the government had issued a fresh order allowing the resumption of inoculation of the first dose of Covishield, albeit in a limited manner.

"Private Covid vaccination centres can continue to administer both doses of the two vaccines. However, they are advised to factor in stock availability for the second dose while planning and publishing the slots for the two doses," the latest order read.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Aug 15 2021 | 6:59 PM IST

Next Story